Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Lupattelli, A; Spigset, O; Björnsdóttir, I; Hämeen-Anttila, K; Mårdby, AC; Panchaud, A; Juraski, RG; Rudolf, G; Odalovic, M; Drozd, M; Twigg, MJ; Juch, H; Moretti, ME; Kennedy, D; Rieutord, A; Zagorodnikova, K; Passier, A; Nordeng, H.
Patterns and factors associated with low adherence to psychotropic medications during pregnancy--a cross-sectional, multinational web-based study.
Depress Anxiety. 2015; 32(6):426-436
Doi: 10.1002/da.22352
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Juch Herbert
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- No previous studies have explored how closely women follow their psychotropic drug regimens during pregnancy. This study aimed to explore patterns of and factors associated with low adherence to psychotropic medication during pregnancy. Multinational web-based study was performed in 18 countries in Europe, North America, and Australia. Uniform data collection was ensured via an electronic questionnaire. Pregnant women were eligible to participate. Adherence was measured via the 8-item Morisky Medication Adherence Scale (MMAS-8). The Beliefs about Prescribed Medicines Questionnaire (BMQ-specific), the Edinburgh Postnatal Depression Scale (EPDS), and a numeric rating scale were utilized to measure women's beliefs, depressive symptoms, and antidepressant risk perception, respectively. Participants reporting use of psychotropic medication during pregnancy (n = 160) were included in the analysis. On the basis of the MMAS-8, 78 of 160 women (48.8%, 95% CI: 41.1-56.4%) demonstrated low adherence during pregnancy. The rates of low adherence were 51.3% for medication for anxiety, 47.2% for depression, and 42.9% for other psychiatric disorders. Smoking during pregnancy, elevated antidepressant risk perception (risk≥6), and depressive symptoms were associated with a significant 3.9-, 2.3-, and 2.5-fold increased likelihood of low medication adherence, respectively. Women on psychotropic polytherapy were less likely to demonstrate low adherence. The belief that the benefit of pharmacotherapy outweighed the risks positively correlated (r = .282) with higher medication adherence. Approximately one of two pregnant women using psychotropic medication demonstrated low adherence in pregnancy. Life-style factors, risk perception, depressive symptoms, and individual beliefs are important factors related to adherence to psychotropic medication in pregnancy. © 2015 Wiley Periodicals, Inc.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Anxiety Disorders - drug therapy
- Anxiety Disorders - psychology
- Cross-Cultural Comparison -
- Cross-Sectional Studies -
- Culture -
- Depressive Disorder - drug therapy
- Depressive Disorder - psychology
- Female -
- Humans -
- Internet -
- Medication Adherence -
- Mental Disorders - drug therapy
- Mental Disorders - psychology
- Pregnancy -
- Pregnancy Complications - drug therapy
- Pregnancy Complications - psychology
- Psychotropic Drugs - adverse effects
- Psychotropic Drugs - therapeutic use
- Surveys and Questionnaires -
- Young Adult -
- Find related publications in this database (Keywords)
- adherence
- pharmacotherapy
- antidepressants
- depression
- anxiety
- pregnancy